ContextVision AB (publ) (OSL: CONTX)

Market Cap	445.64M
Revenue (ttm)	138.42M
Net Income (ttm)	25.83M
Shares Out	77.37M
EPS (ttm)	0.33
PE Ratio	17.41
Forward PE	19.69
Dividend	n/a
Ex-Dividend Date	n/a

Volume	80,361
Open	5.94
Previous Close	5.94
Day's Range	5.76 - 5.94
52-Week Range	5.58 - 9.20
Beta	1.11
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 29, 2024

About ContextVision AB

ContextVision AB (publ), a medical technology software company, provides image analysis and imaging for medical systems in Asia, Europe, and America. The company offers image enhancement software for 2D/3D/4D ultrasound, radiography, magnetic resonance imaging (MRI), and veterinary uses. Its products include Rivent that offers image enhancement and visualization solutions for ultrasound systems for women’s health, general imaging, cardiovascular, and point of care applications; Rivent Mobile, a 2D image enhancement product for handheld units; a...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1983
• Employees: 38
• Stock Exchange: Oslo Børs
• Ticker Symbol: CONTX

Financial Performance

In 2023, CONTX's revenue was 132.60 million, an increase of 7.62% compared to the previous year's 123.21 million. Earnings were 32.73 million, an increase of 13.68%.

Financial numbers in SEK